App vs. Pill – Will digital therapeutics transform how we treat medical conditions?
Life Sciences Leadership With Jasmeet Sawhney
Release Date: 02/02/2022
Software-Driven Transformation of Promotional Measurement, Planning, and Activation
Life Sciences Leadership With Jasmeet Sawhney
Life science organizations must evolve and adapt for future success. Today, Sameer Sardana, Leader of Product Development at Axtria, discusses transforming operational methodologies within life sciences. He delves into the agencies responsible for promotional planning, measurement, and activation, stressing the significance of accurate analysis measurement. Sameer also discusses how MLOps (Machine Learning Operations) workstreams and technologies empower stakeholders and marketers to make real-time promotion decisions, driving pivotal decision-making processes. Sameer adds that this...
info_outline
Building a Commercial Function for Emerging Pharma: Challenges & Learnings
Life Sciences Leadership With Jasmeet Sawhney
Matt Bachman is in charge of the Commercial Operations for Milestone Pharmaceutical company, a biotech company launching a novel treatment for patients with PSVT. Jasmeet and Matt discuss the intricacies of building a commercial function for an emerging pharma company, with Matt highlighting distinctions between working in a large pharmaceutical company versus a smaller one. They also delve into crucial factors influencing decision-making for the future, with a particular emphasis on the formidable challenge of navigating data considerations. Matt introduces a compelling and reflective...
info_outline
Real-World Data in Clinical Trials: Overcoming Challenges to Realize Value
Life Sciences Leadership With Jasmeet Sawhney
Sunil Agarwal is the Principal and Head of Clinical Excellence Practice at Axtria. He leads digital transformation and improvement programs for top pharma companies. Jasmeet and Sunil discuss how patients can be served better by including real-world data in clinical trials and research. Real-world data is not a replacement for traditional trials, but it is helping drive the future evolution and innovation in our industry. The goal is to save lives and provide better patient outcomes. Don’t miss this thought-provoking episode. IN THIS EPISODE: [2:50] Sunil explains the...
info_outline
Capitalizing on the Journey of Data to Drive Efficient Business Insights
Life Sciences Leadership With Jasmeet Sawhney
Ashish Thakur, a strategy and technology executive at Axtria, joins the podcast this week. Ashish has a proven track record of fostering business growth through insightful data utilization for his clients. We'll dive into the concept he terms the "Journey of Data" and use real-life examples to illustrate how this approach can effectively transform struggling businesses into thriving ones. Furthermore, we'll delve into the signal-to-noise ratio, discerning the value of data and distinguishing between meaningful and irrelevant information. Join us for an insightful exploration of the Journey of...
info_outline
The Evolution of Insights & Analytics: How to Seize the Moment and Embrace AI
Life Sciences Leadership With Jasmeet Sawhney
In this episode, we are delighted to have Arvind Balasundaram as our guest, who serves as the head of the Commercial Insights & Analytics (I&A) division at Regeneron, a pioneering biotechnology firm renowned for its groundbreaking medical innovations. Our conversation centers around data, analytics, and artificial intelligence (AI)'s pivotal role in the Life Sciences industry. Arvind shares his insights on the three significant shifts currently unfolding in the realm of data and analytics, and he delves into the crucial consideration of quantity versus quality when making data-driven...
info_outline
The Evolution of Data Science and the Watershed Moment for the Life Sciences Industry
Life Sciences Leadership With Jasmeet Sawhney
It is crucial for life science businesses to keep up with the fast changing technology in their space. Shikha Singhal, the Head of Data Science practice at Axtria joins us to discuss how the shift in technology is impacting life sciences and why data science is suddenly rising to the attention of so many people currently. She discusses the challenges that customers are facing and how companies should build the capabilities to handle the challenges. Tune in today to learn where companies are seeing the most immediate impacts and how to stay ahead of the curve. In This Episode: [3:13] Why...
info_outline
An Ecosystem to Get Patient Engagement Right and Enable an “Everything Patient” Mindset
Life Sciences Leadership With Jasmeet Sawhney
Patient experience and engagement is so vital to their health success. Vishal Singal, a Principal at Axtria, highlights why patient engagement is so critical and what aspects need to be implemented for patients to feel like they are in charge of their health and medical decisions. He is helping pharma companies drive patient engagement by focusing on patient preferences and goals, the limits or tools set in the ecosystem that develops trust and transparency with the patients, integrated experience, and growing patient cohorts. It’s essential for patients to feel like they are in control....
info_outline
The Evolution of Marketing Mix Modeling and Preparing for the Future
Life Sciences Leadership With Jasmeet Sawhney
The evolution of marketing mix modeling is changing how companies do business. Not only is it affecting how analysts and business users relate to the marketing mix, but it is also creating a large shift regarding budgeting. Dr. Rosenwein, the Director of Advanced Analytics & Data Science at Bayer, joins us to discuss what he is seeing with the evolution of marketing mix modeling and how to prepare for the future. He talks about what we have seen so far in the marketing mix evolution and what is the driving force behind it. Dr. Rosenwein also highlights why understanding evolution is...
info_outline
Thriving in the Experience Economy and Managing the Generational Diversity
Life Sciences Leadership With Jasmeet Sawhney
In today’s episode we are joined by Terry Coutsolioutsos, Senior Vice President of Sales Operations, Marketing, and Communications at Siemens Healthineers. We discuss how the “experience economy” has become so critical for business, yet the life sciences industry still struggles to meet the needs of both their customers and employees. Tune in to learn how these companies can use data and analytics, and the right mindset, to adapt quickly. IN THIS EPISODE: [2:50] Why has the “experience economy” become so important, not just for MedTech but for the success of every...
info_outline
Post-COVID Mindset — How the Modern Field Force Operations Must Evolve
Life Sciences Leadership With Jasmeet Sawhney
In today’s episode, we are joined by Mehmet Bozbay, Head of Field Deployment, Incentives & Analytics at Astellas Pharma US. We discuss the evolution of the field force and how it plays into the success of sales reps. Mehmet talks about the shift seen since the pandemic and what areas need enhancing to create the proper execution and effectiveness for success. He talks about how the role of sales reps is evolving and where customers are expecting more. Tune in to learn how healthcare providers and sales reps are changing the game, where they are investing, and other tips on improving the...
info_outlineIn this episode, Ivan Pandiyan, Vice President of Global R&D at Natus Medical Incorporated, joins us to discuss the evolution of digital therapeutics in contrast to traditional therapeutics. First, we talk about how digital therapy is being used to diagnose and treat diseases and the role of a biomarker in identifying a specific disease. Then we look at the role of the Food and Drug Administration (FDA) enabling the environment for research and development of digital therapeutics as an alternative to traditional therapy. Finally, we discuss the success digital therapeutics have had and its future role in the pharma and life sciences industry.
IN THIS EPISODE:
- [02:35] What are digital therapeutics, and how are they different from traditional therapies?
- [04:10] The discovery of digital therapeutics and how do we go about finding and validating the efficacy of digital therapies.
- [08:07] How are regulatory bodies ensuring the safety of digital therapies and what are the guidelines and boundaries established by the FDA?
- [12:50] The role of software, data, and artificial intelligence in enabling digital therapeutics.
- [17:05] The maturity of digital therapeutics and the challenges companies face in development.
- [19:00] The success of digital therapeutics.
KEY TAKEAWAYS:
- Digital therapeutics are real, and they are the future.
- We will see them either replace or complement traditional therapies.
- Digital therapeutics have the potential to cure diseases without the chemical side effects that come with traditional pharma therapies.
- Digital therapeutics are currently applied in targeted areas. More data will enable further development of the ecosystem and the digital therapy space.
LINKS MENTIONED:
Axtria:
Ivan Pandiyan on LinkedIn:
https://www.linkedin.com/in/ivan-pandiyan-b0819b5/
BIO:
Ivan is a global product and technology visionary who has launched multiple innovative and disruptive products from concept to commercialization. He has expertise in strategic planning and growth strategies, and effectively translates business goals and customer needs to develop and launch highly complex and innovative products. Ivan serves as a mentor and senior advisor at innovative startup incubators such as gBETA Medtech and MN Cup. He is an expert in technology led strategy planning and exponential growth.
Ivan is currently the Vice President of Global R&D at Natus Medical Incorporated. In this role he is responsible for teams across North America, Europe, and Asia-Pacific. He leads technology and product strategy roadmaps, and achieves strategic innovation through research, partnerships, technology licensing, and acquisitions.